The amplitude of mood and energy level is different in every individual – sometimes a bit higher, sometimes lower, sometimes changing, and for some people rather stable. However, if the mood drops to a very deep low and there is an almost complete lack of energy, this person might be experiencing a depressive episode. Or to the contrary, if a person experiences excessive energy and feels extremely positive, this might be a manic episode. These kinds of episodes are characteristic of a type of psychiatric diseases called mood or affective disorders.
affective disorder

Definition of Affective Disorders

Affective disorders are episodically occurring diseases. According to the quality and the direction of the mood amplitude, affective disorders are categorized as unipolar and bipolar disorders. Unipolar disorders refer to deflections of mood in one direction only, namely downwards (depressive episodes). Bipolar disorders, in turn, include not only the mentioned downward deflection but also manic or hypomanic episodes. Those are episodes with an extremely elevated mood level. So bipolar disorders are characterized by two different mood deflections.

In addition to the determination in which direction(s) the mood deflects, the frequency of these mood levels is reported (once vs. recurrent) as well as their severity (mild, moderate, severe). Affective disorders are categorized in the ICD-10 as follows:

  • F30. – Manic episode
  • F31. – Bipolar affective disorder
  • F32. – Depressive episode
  • F33. – Recurrent depressive disorder
  • F34. – Persistent affective disorder
  • F38. – Other affective disorder
  • F39. – Unspecified affective disorder

Beside the ICD-10, the American DSM (Diagnostic and Statistical Manual of Mental Disorders) is also an important point of reference for the classification of psychiatric diseases. Especially for the understanding of current research, it is absolutely necessary to be familiar with the DSM.

The following table provides a comparison of the classification of affective disorders in the DSM-V and ICD-10:

Major depressive disorder, single episode Depressive episode
Major depressive disorder, recurrent Recurrent depressive disorder
Bipolar I disorder Manic/bipolar affective disorder
Bipolar II disorder Manic/bipolar affective disorder
Persistent depressive disorder Dysthymia
Cyclothymic disorder Cyclothymia

Unipolar Affective Disorder

Unipolar affective disorders are all depressive diseases. They include single depressive episodes, recurrent depressive disorder, and dysthymia. Actually, purely manic symptoms would have to be considered unipolar as well. However, this is highly uncommon, so that manic episodes are usually attributed to a bipolar disorder.

The Depressive Episode as an Acute Condition

Symptoms and Classification

The depressive episode describes the presence of depressive symptoms. The diagnosis according to DSM-V as well as ICD-10 is based on major and minor criteria. This includes that over a time of at least two weeks unusually negative mood levels and loss of joy and interests have to dominate for most of the day.

The severity of the episode depends on how many symptoms occur simultaneously. In the ICD-10, the severe depressive episode is additionally characterized by the presence or the absence of psychotic symptoms. Depressive symptoms are manifold. Next to affective symptoms, changes on the cognitive, behavioral, and somatic level are possible.


At least 5 of the following symptoms are present over at least 2 weeks. One of these symptoms has to be ‘depressed mood’ or ‘markedly diminished interest’. Depressed mood or markedly diminished interest plus at least three of the following symptoms:

  • Significant weight change or change in appetite
  • Insomnia or hypersomnia
  • Psychomotor agitation or retardation
  • Fatigue or loss of energy
  • Feeling of worthlessness or guilt
  • Diminished ability to think or concentrate, or indecisiveness
  • Thoughts of death or suicide, suicide plans or attempts

Negative criteria:

  • Criteria do not match the criteria of mixed bipolar disorder
  • Symptoms cause distress and impairment in a clinically significant manner
  • Symptoms are not due to direct physical effect of substances or a medical condition
  • Symptoms cannot be attributed to bereavement


The inclusion criteria of a depressive episode are fulfilled when at least 2 (or 3 for a severe episode) of the following symptoms are present over at least 2 weeks:

  • depressive mood to an extent that is significantly unusual for the affected person, for most of the day, almost every day, and mostly unresponsive to circumstances
  • loss of interest and enjoyment of activities that were usually pleasurable or (and)
  • reduced energy or increased fatigue

Plus at least two of the following symptoms:

  • Loss of self-esteem or self-confidence
  • Unreasonable self-accusations or severe, unreasonable feelings of guilt
  • Recurrent thoughts of death or suicide; suicidal behavior
  • Complaints or evidence of diminished abilities to think or concentrate, or indecisiveness
  • Psychomotor agitation or retardation (subjective or objective)
  • Disturbed sleep of any kind
  • Loss of appetite or increased appetite with according changes in weight

Classification of Severity:

  • Mild: two major criteria and at least two minor criteria
  • Medium: two major criteria and at least four minor criteria
  • Sever: three major criteria and at least five minor criteria

Epidemiology of Depressive Episodes

The first depressive episodes usually occur in young adults between the ages of 25 and 35. If left untreated, an episode lasts for roughly three to four months and then remits completely in 70 – 80 % of the cases. In the other 20 – 30 %, residual symptoms remain for months or even years.

The more frequently a patient suffers from depressive episodes, the greater is the probability that symptoms persist. Point prevalence of depressive symptoms is approximately 8.1 % (women: 10.2 %; men: 6.1 %).

Recurrent Depressive Disorder

Unfortunately, the first depressive episode is very often not the only one. One third of the patients experiences clearly definable episodes of major depression over and over again, while for another third the episodes are chronic and proceed with only partial or no remission.

The more frequently the episodes occur, the greater is the probability for re-occurrence. It is estimated that 11.6 % of the adult German population suffer from a depressive disorder at some point in their life (women 15.4 %; men 7.8 %).


Dysthymia is not a complete manifestation of major depression: symptoms present in a less severe form over a period of at least two years. This would include, for example, a continuously subdued mood and loss of joy and interests, but functioning in occupational life would be retained. In addition to dysthymic symptoms, ‘actual’ depressive episodes might occur. This is then called a double depression.

Epidemiology of Dysthymia

Life prevalence is estimated to be 2.5 – 6 %. Point prevalence in 2011 was estimated to be 2.0 %. Dysthymia often begins before the 20th year of life and lasts five years on average.

Development of Unipolar Affective Disorders

The development of a unipolar affective disorder is not monocausal; it is rather an interaction of numerous predisposing factors and events. The standard explanatory model has become the diathesis-stress model, which tries to explain the interactions of different influences and the formation of the disease. Different biological, psychosocial, and psychodynamic factors are discussed as influencing factors.


Image: “Vulnerabilitäts-Stress-Modell” from mpluess. License: Public Domain

Genetic predisposition has a moderate influence on the development of a unipolar affective disorder. However, this relationship does not distinctly show in the chronic unipolar disorder (dysthymia). Furthermore, disorders in the neurophysiological system, a strong activation of the hypothalamus pituitary adrenal axis (HPA axis) with increased release of cortisol, neurobiological changes (decreased volume of the orbitofrontal cortex, hippocampus; elevated activity of the amygdala), reduced phases of deep sleep, and increased darkness (seasonal affective disorder, ‘winter blues’) have to be mentioned.

Psychosocial circumstances that can cause depressive symptoms include stress triggering events, individual vulnerability, personality, and social support. Psychodynamic models assume an early development and maintaining of dysfunctional schemes and beliefs or acquired helplessness, which leads to negative thought spirals and beliefs, which are a key characteristic of depressions.

Further risk factors for the development of a depressive episode are age, gender, and socio-economic status. For example, the highest prevalence can be found in the age group of 18 – 29 and in subjects with low socio-economic status, according to a German study on adult health.

Generally, women are affected almost twice as much as men. Further risk factors are, as mentioned, stressful life time events (like, e.g., experiencing traumas), living as a single, and pre-existent comorbidities. Comorbidities can be of psychic (e.g., anxiety disorders, substance disorders) and somatic nature (diabetes mellitus, CHD).

There is no specific cause-effect direction since depressive symptoms can be both the cause and the consequence of other diseases.

Diagnostics as Primary Care Physician

If you are not a psychiatrist, it is not always easy to recognize depression. Often, patients report unspecific physical symptoms like back and/or abdominal pain. This is called a ‘somatic depression’.

The German national guideline for unipolar depression lists the following ten symptoms that might suggest a depressive episode:

  • General physical fatigue, languor
  • Sleeping disorders
  • Appetite disorders, stomach pressure, weight loss, obstipation, diarrhea
  • Diffuse headache
  • Pressure sensation in throat and chest, globus sensation
  • Functional disorders of heart and circulation (e.g. tachycardia, arrhythmia, syncopes)
  • Breathing (e.g. dyspnea), stomach and intestine
  • Vertigo, flickering vision, visual impairments
  • Muscle tension, diffuse neuralgiform pain
  • Loss of libido, suspension of menstruation, impotence, sexual function disorders
  • Memory disorders

If, for example, referrals to different medical specialists or consults about symptoms that cannot be explained somatically become overly frequent, the general practitioner should consider a depression. Then, he/she should cautiously inquire about  mood and energy level and general ability to experience joy in the past four weeks.

Also, there are easy screening questionnaires that facilitate the assessment if depressive symptoms are present or not. Even if the patient does not experience negative mood, it is generally possible that inexplicable somatic symptoms can be caused by a depression. In this case, this is called masked depression.

In approximately one third of patients with a unipolar disease, diagnosis has to be changed to a bipolar disorder in the further progression of the disease. Especially bipolar disorder II can be underestimated in regard to its frequency since hypomanic symptoms are experienced as pleasant and are therefore not reported by the patient himself or are not asked for at all.

Bipolar Disorders

Symptoms and Classification

Bipolar disorder is also an affective disease. It is characterized by a recurrent change of mood between the poles of (hypo)mania and depression, which cannot be influeced voluntarily; also, both extremities can be present at the same time (mixed episode). Between the individual episodes, there are symptom-free (euthymic) intervals.

If the affective episodes change in quick sequence with at least four definable episodes in a year, this is called rapid cycling.

The ICD-10 describes a manic episode with elevated, elated, or irritable mood, which is perceived by the affected person as a significantly abnormal mood level. This change in mood must dominate and last for at least one week (unless hospitalization becomes necessary).

Additional features (at least three or four if the mood is only irritable) have to be present and the daily routine has to be severely disturbed. Manic symptoms are e.g. increased activity or motor restlessness, increased talkativeness, flight of ideas, or the subjective feeling of rushing thoughts, loss of normal social inhibition, which leads to inappropriate behavior, decreased need for sleep, inflated self-esteem or megalomania, distractibility or continuous change of activities and plans, daring or reckless behavior, whose risks are not recognized by the affected person, and increased libido or sexual indiscretion.

In hypomania, these symptoms are less extreme and distinct, but noticeably ‘different’ than normal for the affected (and even more often) for the environment. After a certain time, the mood shifts and the patients slide into a depressive episode.

Different from the ICD-10, the DSM differentiates between bipolar disorder I, bipolar disorder II, and cyclothymia. In contrast, the ICD-10 only codes the currently present episode.

Bipolar disorder I is characterized by the occurrence of one or several manic episodes and episodes of major depression (= mania + depression).

Bipolar disorder II is characterized by the occurrence of recurrent episodes of alternating major depressions and hypomanic episodes (= depression + hypomania).

Cyclothymia describes a milder form of bipolar disorder. Similar to dysthymia, changes in the mood level can be observed over a longer period of at least two years. However, the criteria of a (hypo)manic or depressive episode are not completely met.

Epidemiology of Bipolar Disorders

Lifetime prevalence of bipolar disorders is estimated to be 3.9 to 4.4 % (bipolar disorder I: 1 %, bipolar disorder II: 1.1 %). The onset of bipolar disorders mostly occurs in the teenage or young adult age. The gender proportion is balanced for bipolar disorder I; bipolar disorder II is more frequent in women.

Even a great event can turn into a disease trigger

The pathogenesis of bipolar disorders is not completely understood. A multifactorial genesis is assumed. As for unipolar disorders, the diathesis-stress model provides a basis for understanding the development of bipolar disorders.

Genetic disposition leads to increased vulnerability for the development of the disease. Besides this, environmental factors such as biographical events, coping strategies, drug consumption, stress, and other factors play a role in the development of the disease.

So-called stressors, which are not necessarily of negative nature, can trigger an initial phase. For example, the birth of a child is often a trigger of bipolar disorders in women. Subsequent phases, however, often occur without a relatable event.

Mood changes determine diagnosis

Diagnosis of bipolar disorders can only be traced by longitudinal observations if at least two different definable affective episodes have occurred over the course of time. The diagnosis of bipolar disorder I is relatively easy due to its conspicuous manifestations.

It is assumed that a part of unipolar depressive patients should rather be classes as bipolar disorder II; however, the assessment of hypomanic symptoms is difficult since they are experienced as pleasant by the patient and are seldomly reported spontaneously.

Comorbidity of Affective Disorders

Unipolar and bipolar disorders are frequently accompanied by other mental and somatic diseases. Frequent psychiatric comorbidities are anxiety disorders, substance abuse and addiction, and impulse control disorders.

On the somatic level, diseases of the cardiovascular system and the endocrine system like diabetes mellitus and the metabolic syndrome are frequently observed. But also musculoskeletal diseases and migraine often accompany the affective disorder.

Mortality due to cardiovascular diseases is double or triple. Generally, mortality due to increased suicide risk is increased. It is estimated that approximately 15 % of affective patients commit suicide.

Treatment of Affective Disorders

Treatment and the objectives of treatment differ for unipolar and bipolar disorders in several aspects. In treating unipolar affective disorders, symptom reduction is the priority. The treatment of bipolar affective disorders is aimed at elimination of episodes. This requires mandatory medication, whereas a milder unipolar depressive episode can be treated with alternative measures.

The treatment objecitve for unipolar depressive disorders is the reduction of the ocurring symptoms and reaching a complete remission with rehabilitation of occupational and psychosocial performance as well as mental balance. Another objective is to avoid recurrence. Important pillars of treatment for unipolar affective disorders are medication with antidepressants and psychotherapy.

There are various different substances that are used as antidepressive medication. The most important are tri- (and tetracyclic) antidepressants (TCA), the selective serotonin-reuptake-inhibitors (SSRI), the selective serotonin-and-noradrenalin-reuptake-inhibitors (SSNRI), and the selective noradrenalin-reuptake-inhibitors (SNRI).

Further antidepressive substances are, for example, the selective noradrenalin-dopamine-reuptake-inhibitor bupropion or the serotonin 5-HT2C-receptor-antagonist agomelatin.

All antidepressants need some time to unfold their full effect. Additionally, side effects complicate the initial phase. This difficult time should then be cushioned therapeutically since the risk for the patient to abandon therapy is especially high in this initial phase.

The most prescribed antidepressants are of the class of the selective serotonin-reuptake-inhibitors (SSRI). Representatives of SSRI are fluoxetine, citalopram, escitalopram, fluvoxamine, paroxetine, and sertraline. The SSRI increase the amount of serotonin in the synaptic cleft through the inhibition of reuptake transporters. They often lead to gastrointestinal complaints like nausea and sexual function disorders. However, they generally have fewer side effects than the tri- and tetracyclic antidepressants since they do not block any other receptors.

Tricyclic antidepressants (TCA) unfold their effect through the inhibition of the reuptake of serotonin and noradrenalin from the synaptic cleft. Additionally, they block several receptors (e.g., central and peripheral cholinergic, histaminergic, or alpha1-adrenergic receptors), which can cause a series of side effects, as for example cardiovascular symptoms (orthostatic hypotension, stimulus conduction disorders, tachycardia). Representatives of the TCAs are amitryptiline, imipramine, and clomipramine.

Selective serotonin and noradrenalin-reuptake-inhibitors (SSNRI) inhibit the reuptake of serotonin and noradrenalin. This way, the concentrations of serotonin and noradrenalin in the synaptic cleft are increased. Known side effects are loss of appetite, nausea, obstipation, mouth dryness, sexual function disorders and restlessness, sleeping disorders and in case of higher dosages, hypertension. Representatives of SSNRIs are venlafaxine and duloxetine.

The selective noradrenalin-reuptake-inhibitors (SNRI) block the reuptake of noradrenalin from the synaptic cleft and therefore increase its concentration. Side effects are triggered by the noradrenergic effect, which is why this treatment also leads to increased mouth dryness, sexual dysfunction, and sleeping disorders. A common representative of SNRIs is reboxetine.

The overall objective in treating bipolar disorders is elimination of episodes. Further goals are maintaining or regaining a psychosocial functional level as high as possible. For treating bipolar disorders, long-term medication is absolutely necessry, which can be supplemented by further treatment measures like socio-therapy. A distinction is made between acute treatment and  phase prophylaxis.

In acute treatment, the goal is to decrease symptoms of maniac, hypomanic, depressive, or mixed episodes. This is achieved by administering the appropriate medication, such as antidepressants, typical and atypical neuroleptics, mood stabilizers, and benzodiazepines.

Typical and atypical neuroleptics that play an important part in treating a manic phase are, e.g., quetiapine, clozapine, or risperidone. Furthermore, benzodiazepines like lorazepam are used for curbing manic behavior. Antidepressants are used for treating an acute depressive episode.

There is the possibility that the intake of an antidepressant may trigger a so-called ‘switch’. In this case, the patient experiences a mood shift from an acute depressive episode to an acute manic episode. Predisposing medicaments for a switch are TCA and SNRI.

In phase prophylaxis, the renewed occurrence of an episode is tried to be avoided or delayed. Besides mood stabilizing medication such as lithium, valproic acid, carbamacepine, and lamotrigine, other therapeutic procedures like psychotherapy or psycho-education can be utilized. The personal environment should always be included in treatment since relatives often recognize the first symptoms earlier than the affected person him-/herself.

Psychotherapeutic Methods

Well-proven is the efficacy of cognitive behavior therapy (CBT) as treatment of affective disorders. CBT aims to make the relations between thoughts, feelings, and behavior more conscious. The goal is monitoring and correcting dysfunctional attitudes and, for instance, building up activity step-by-step. In treatment of bipolar affective disorders, CBT can help to promote medication compliance.

cognitive behavior therapy

Image: “The diagram depicts how emotions, thoughts, and behaviors all influence each other. The triangle in the middle represents CBT’s tenet that all humans’ core beliefs can be summed up in three categories: self, others, future.” by Urstadt. License: CC BY 3.0

Prognosis for Affective Disorders

Adverse processes of the disease are to be expected mostly in older patients, in patients with early disease onset, in cases with mixed symptoms, a high number of episodes, family predisposition, chronic family or occupational stressors, and existing comorbidity.

Generally, however, affective disorders are manageable. A requirement for effective treatment is active participation of the patient, which includes medication compliance and engagement in psychotherapeutic procedures.

Popular Exam Questions on Affective Disorders

Correct answers can be found below the references.

1. A 45-year-old teacher consults her primary care physician with complaints about massive sleeping problems. She says she has been having these problems for years now, but recently, they have gotten worse to a degree that she is no longer able to fulfill her job requirements, which is why she asks her doctor for a sick leave. She is only sleeping 2 to 3 hours per night. Most of the times, she wakes up in the middle of the night, starting to brood and lying awake for the rest of the night. During the day, she feels exhausted, slack and without energy. It is worst in the morning, while improving throughout the day and feeling best in the evening. She says to be desperate by now and no longer able to feel joy. She feels without power during the day and has difficulties concentrating, which is why her teaching job feels like an overload. She is constantly nervous and feels like she is going crazy. During the day, especially in the morning, she feels sick and has already lost several pounds. She constantly feels like a loser, having done everything wrong in her entire life. Based on these reportings, which of the following medication with sedative effect is, in addition to psychotherapy,  a reasonable choice of treatment for this patient?

  1. Fluoxetin
  2. Moclobemid
  3. Trimipramin
  4. Venlafaxin
  5. Zolpidem

2. For a severe depressive episode according to ICD-10, which of the following symptoms is the least characteristic?

  1. Diminished ability to think
  2. Paranoia
  3. Feeling of numbness
  4. Early morning low
  5. Waking up early

3. The ICD-10 features an entire section (F3) on Affective Disorders. This refers primarily to the following disorder:

  1. Transsexualism
  2. Manic episode
  3. Anorexia nervosa
  4. Paranoid psychosis
  5. Pathological intoxication
Lecturio Medical Courses


Becker-Pfaff, Engel: Fallbuch Psychiatrie, Georg-Thieme Verlag, 2006.

Wittchen&Hoyer: Klinische Psychologie & Psychotherapie, Springer, 2006.

Comer: Klinische Psychologie, Pearson Studium, Pearson Education Deutschland, 2009.

Prävalenz von depressiver Symptomatik und diagnostizierter Depression bei Erwachsenen in Deutschland – Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1) Busch MA, Maske UE, Ryl L, Schlack R, Hapke U (2013) Bundesgesundheitsblatt • 56(5/6):733-739 • DOI 10.1007/s00103-013-1688-3

Correct Answers: 1C, 2B, 3B

Leave a Reply

Your email address will not be published. Required fields are marked *